<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04963374</url>
  </required_header>
  <id_info>
    <org_study_id>Peking UTH</org_study_id>
    <nct_id>NCT04963374</nct_id>
  </id_info>
  <brief_title>the Effectiveness of Different Risk Scales In Predicting VTE in Respiratory Inpatients</brief_title>
  <official_title>Comparative Analysis of the Effectiveness of Different Risk Scales in Predicting Combined Venous Thrombophilia in Respiratory Inpatients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking University Third Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking University Third Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare the predictive effectiveness of the Caprini risk assessment model, the Padua risk&#xD;
      assessment model and the VTE risk assessment in medical patients mentioned in the 2018&#xD;
      edition of the Guidelines for the diagnosis, treatment and prevention of pulmonary&#xD;
      thromboembolism on the risk of concomitant VTE in respiratory inpatients to provide a basis&#xD;
      for clinical VTE assessment and treatment.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A case-control study was used to collect patients who developed VTE during hospitalization in&#xD;
      the Department of Respiratory Medicine at Peking University Third Hospital Hospital from&#xD;
      January 2015 to December 2020 as the case group, and 2-fold patients who did not develop VTE&#xD;
      matched to the case group (age, sex, ADL score, diagnosis, and length of hospitalization) as&#xD;
      the control group. The general status of the patients was also assessed using the Padua risk&#xD;
      model, the Caprini risk model, and the VTE risk assessment scale for medical patients&#xD;
      mentioned in the 2018 edition of the Guidelines for the diagnosis, treatment, and prevention&#xD;
      of pulmonary thromboembolism, and the relevant items involved in the assessment form were&#xD;
      obtained by reviewing the cases.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>VTE incidence</measure>
    <time_frame>during hospitalization， an average of 2 weeks</time_frame>
    <description>VTE incidence in patients with high risk of VTE</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Venous Thromboembolism</condition>
  <arm_group>
    <arm_group_label>respiratory inpatient</arm_group_label>
    <description>respiratory inpatient with VTE</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>risk evolution scale</intervention_name>
    <description>Padua score、Caprini score、Prime score</description>
    <arm_group_label>respiratory inpatient</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        From January 2015 to December 2020, inpatients in respiratory department, Third Hospital of&#xD;
        Peking University&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age more than 18y respiratory inpatient&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with deep vein thrombosis or pulmonary thromboembolism, sequelae of deep vein&#xD;
             thrombosis, and thrombosis in other parts of lower limbs were diagnosed; Patients with&#xD;
             severe coagulation dysfunction or other hematological diseases&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jing Zhang, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Peking UTH</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jing Zhang, MD</last_name>
    <phone>8601082266941</phone>
    <email>jing-amy@126.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>dongfang zhao</last_name>
    <phone>8601082265020</phone>
    <email>13522391517@126.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Peking UTH</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100191</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jing Zhang, MD</last_name>
      <phone>8601082266941</phone>
      <email>jing-amy@126.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Luo XY, Zhang FX. [Validation of the Caprini risk assessment model for venous thromboembolism in Chinese hospitalized patients in a general hospital]. Zhonghua Yi Xue Za Zhi. 2017 Jun 27;97(24):1875-1877. doi: 10.3760/cma.j.issn.0376-2491.2017.24.007. Chinese.</citation>
    <PMID>28648012</PMID>
  </reference>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 29, 2021</study_first_submitted>
  <study_first_submitted_qc>July 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 15, 2021</study_first_posted>
  <last_update_submitted>July 8, 2021</last_update_submitted>
  <last_update_submitted_qc>July 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>VTE</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thromboembolism</mesh_term>
    <mesh_term>Venous Thromboembolism</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

